Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching Strategies to Risperidone from Olanzapine
NCT00378183Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2001
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of risperidone in schizophrenia, schizoaffective disorder, sponsored by Janssen Pharmaceutical. Started Feb 2001; status: completed.
02
Drugs
risperidone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00378183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00378183.